SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001013594-16-001292
Filing Date
2016-10-28
Accepted
2016-10-28 09:19:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 OCTOBER 27, 2016 sarepta13g-102716.htm SC 13G 63784
  Complete submission text file 0001013594-16-001292.txt   65701
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Subject) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-54847 | Film No.: 161957110
SIC: 2834 Pharmaceutical Preparations

Mailing Address 888 SEVENTH AVENUE 32ND FLOOR NEW YORK NY 10019
Business Address 888 SEVENTH AVENUE 32ND FLOOR NEW YORK NY 10019 212-554-2500
Tourbillon Capital Partners, L.P. (Filed by) CIK: 0001592476 (see all company filings)

IRS No.: 460724833 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G